Novo Nordisk, Eli Lilly fall after Trump comments on weight loss drug pricing
Investing.com - Raymond James lowered its price target on CME Group (NASDAQ:CME) to $307.00 from $309.00 while maintaining an Outperform rating on the stock. The company’s shares, which have delivered an impressive 18.57% return year-to-date, currently trade near their 52-week high of $290.79.
The firm cited recent updates to its model ahead of CME Group’s third-quarter 2025 results as the reason for the minor $2 reduction in the price target.
Raymond James noted that CME Group’s suite of risk management tools positions the company well amid volatile global macroeconomic and geopolitical conditions, though it acknowledged that trading volumes can moderate when volatility subsides, as occurred in recent months.
The research firm expressed little concern about the temporary slowdown in trading activity, stating that "volatility always seems to find a way to re-enter the global macroeconomic landscape."
Raymond James views CME Group’s risk/reward profile as attractive, noting the stock currently trades at approximately 23 times the firm’s estimated 2026 non-GAAP earnings per share.
In other recent news, CME Group reported its second-highest August average daily volume of 28.1 million contracts, slightly below the record set in August 2024. The company also achieved a record monthly average daily volume in cryptocurrency products, with 411,000 contracts and a notional value of $14.9 billion. CME Group plans to launch options on Solana and XRP futures on October 13, 2025, pending regulatory review, following significant growth in its cryptocurrency futures products. Additionally, CME Group announced plans to expand its cryptocurrency futures and options trading to 24/7 availability starting in early 2026, subject to regulatory approval. The firm is also working to expand its cross-margining agreement with The Depository Trust & Clearing Corporation to end-user clients by December 2025, aiming to increase margin savings and capital efficiencies. Furthermore, CME Group’s credit futures have surpassed 450,000 contracts in trading volume, with open interest reaching 6,800 contracts representing over $700 million in notional value. These developments highlight CME Group’s ongoing efforts to enhance its offerings in the derivatives market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.